Spectral Medical Inc T.EDT

"the best way to enhance shareholder value is" simply

[Stocktree]

never what Spectral management will do.

So whatever pumpers say would be a good strategy, it doesn't matter.
Spectral is not in the business of creating wealth for long shareholders.
You only can make a buck if you know what is going to happen in the next few days/weeks and you skim the fat of the suface of the share pool before the SP settles at a puzzling level for months.

And you better not listen to any poster who seems unphased in their belief in Spectral at this time.
Remember, they were advancing the debunked assumption that the trial would stop at 90 if the numbers were good. Well, since that is not happening, the numbers are not good, or they were always just BSing.

[ChesterLives]

Stocktree, Ohhh who to believe? You, spamme, BSW etc. Or the FDA, Toray, Baxter, Birchill, 20 lead investigators from some of the world's most prominent hospitals, the analyst and Dr. Kellum. All who have a stake in PMX's success. Tough choice!

[Stocktree]

- FDA did not pre-approve PMX, so nothing there. - Baxter just bought 10 yrs of potential distribution for nothing. That absolutely does not confirm anything great about the results, unless you have the dumbest management of all time. - What did Toray and Birchill say about this new development? Right, nothing. - This team of investigators (with Kellum on board, which is a conflict of interest

[Accountprince]

So Stockboy is now claiming to "have a stake in PMX's success"?  After claiming proudly that he doesn't own anything anymore and is merely here to prevent the public from being scammed?  That constitutes speaking from all his orifices at once. Stockboy you now have the same level of credibility as Stoopid54321.  Go away.  Or get treatment.  Or both.

[Stocktree]

Accuntpice, please find the post where I say I don't have any shares. I don't have as much as others here, but I still hurt when management screws me and all real non insider promoting shareholders. And if I had no shares, why would I refrain from helping investors not fall into a trap or from qualifying the investment? The mere fact that you want me or any honest posters from

[ChesterLives]

Stocktree, I forgot the findings from the journal Critical Care. You'll find the 95% probability of PMX success highlighted on the bottom of page 11 in today's investor deck. The entire deck is worth a read... all good.

[Stocktree]

What the study actually says, is IF you accept their mathematical methods, you would find a 95% prob. of success. It also says, may I repeat: "The question of the importance of type I error (or p-values) in study design cannot be resolved here. However, we have presented a study design that transparently adheres to Bayesian principles of data synthesis, along with its frequentist

[ChesterLives]

Stocktree- have you read the new investor deck or is that not part of your assignment.

[Stocktree]

You have several times argued that, as per "Critical Care" (which is incorrect, they published the study, they have no part in it)... so then per the study, there is a 95% chance of success. I have answered that. As for the rest, I will not base my expectations on Spectral management's promotional decks, as they have been unreliable in the past and change as they go. Remember that